In 2025, Medtronic completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Medtronic has also provided a category-level breakdown for 15 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 174,000a | 150,000a | 157,000a | |
Total Scope 2 | ||||
Market-Based | 79,000a | 118,000a | 149,000a | |
Location-Based | 199,000a | 209,000a | 217,000a | |
Unspecified Calculation Method | N/A | N/A | N/A | |
Total Scope 3 | 5,265,000a | 5,557,000a | 3,594,000a | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 5.1883a | 4.6348a | 5.0277a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Medtronic amounted to 373,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Medtronic increased by 3.9%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2025, the total Scope 1 emissions of Medtronic were 174,000 metric tons of CO₂ equivalent (tCO₂e).a
Since 2019, Medtronic's Scope 1 emissions have increased by 176.63%, reflecting a rising long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2024), Medtronic's Scope 1 emissions increased by 16%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2025, Medtronic reported Scope 2 greenhouse gas (GHG) emissions of 79,000 tCO₂e using the market-based method and 199,000 tCO₂e using the location-based method.a
Compared to the previous year (2024), Medtronic's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Medtronic's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Medtronic reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2025, Medtronic reported 5,265,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Medtronic includes a breakdown across 15 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Medtronic reported total Scope 3 emissions of 5,265,000 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 91.89% of these emissions originated from upstream activities such as purchased goods and capital goods, while 8.11% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2024), Medtronic's Scope 3 emissions remained relatively stable, indicating that Medtronic's emissions have plateaued with no significant change in its value chain footprint.a
In 2025, Medtronic reported emissions for 15 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
In 2025, the largest contributors to Medtronic's Scope 3 emissions were:a
In 2025, Medtronic reported Scope 1 greenhouse gas (GHG) emissions of 174,000 tCO₂e and total revenues of USD 33,537 millions. This translates into an emissions intensity of 5.19 tCO₂e per millions USD.a
In 2025, Medtronic reported a Scope 1 emissions intensity of 5.19 tCO₂e per millions USD. Compared to the peer group median of 2.58, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2025, Medtronic ranked 21 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Medtronic among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2025, Medtronic reported a total carbon footprint of 5,638,000 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 4.7% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Medtronic's total carbon footprint was Scope 3 emissions, accounting for 93.38% of the company's total carbon footprint, followed by Scope 2 emissions at 3.53%.a